Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114757164 | 11475716 | 4 | F | 201508 | 20160712 | 20150909 | 20160720 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-059568 | BRISTOL MYERS SQUIBB | 50.73 | YR | F | Y | 0.00000 | 20160720 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114757164 | 11475716 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 20 MG, BID | 1360 | MG | Y | 21436 | 20 | MG | BID | ||||
| 114757164 | 11475716 | 2 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 15 MG, BID | 1360 | MG | Y | 21436 | 15 | MG | BID | ||||
| 114757164 | 11475716 | 3 | SS | ABILIFY MAINTENA | ARIPIPRAZOLE | 1 | Intramuscular | 400 MG, QMO | Y | 0 | 400 | MG | INJECTION | /month | |||||
| 114757164 | 11475716 | 4 | SS | LOXAPAC /00401801/ | LOXAPINE SUCCINATE | 1 | Unknown | 1 DF, UNK | Y | 0 | 1 | DF | |||||||
| 114757164 | 11475716 | 5 | C | VALIUM | DIAZEPAM | 1 | Unknown | 1 DF, Q6H | 136 | DF | Y | 0 | 1 | DF | QID | ||||
| 114757164 | 11475716 | 6 | C | OLANZAPINE. | OLANZAPINE | 1 | Unknown | 10 MG, QD | 320 | MG | Y | 0 | 10 | MG | QD | ||||
| 114757164 | 11475716 | 7 | C | ZOPICLONE | ZOPICLONE | 1 | Unknown | UNK, PRN | Y | 0 | 1 | DF | |||||||
| 114757164 | 11475716 | 8 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Oral | UNK, PRN | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114757164 | 11475716 | 1 | Product used for unknown indication |
| 114757164 | 11475716 | 3 | Product used for unknown indication |
| 114757164 | 11475716 | 4 | Product used for unknown indication |
| 114757164 | 11475716 | 5 | Product used for unknown indication |
| 114757164 | 11475716 | 6 | Product used for unknown indication |
| 114757164 | 11475716 | 7 | Product used for unknown indication |
| 114757164 | 11475716 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114757164 | 11475716 | OT |
| 114757164 | 11475716 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114757164 | 11475716 | Erysipelas | |
| 114757164 | 11475716 | Off label use | |
| 114757164 | 11475716 | Pancytopenia | |
| 114757164 | 11475716 | Pyelonephritis | |
| 114757164 | 11475716 | Septic shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114757164 | 11475716 | 1 | 20150711 | 20150813 | 0 | |
| 114757164 | 11475716 | 3 | 20150730 | 0 | ||
| 114757164 | 11475716 | 4 | 20150711 | 20150815 | 0 | |
| 114757164 | 11475716 | 5 | 20150711 | 20150815 | 0 | |
| 114757164 | 11475716 | 6 | 20150711 | 20150811 | 0 | |
| 114757164 | 11475716 | 7 | 20150815 | 0 |